Impotence vacuum therapy breaking news.

Future treatments for erectile dysfunction focus on providing
medications that are more effective, work rapidly, and have fewer, if any, side
effects than currently available treatments. Currently there are three
oral medications available to treat ED - Cialis, Levitra and Viagra. A
number of pharmaceutical companies are researching new treatments for ED, and
many new options may be just around the corner. These include:

Uprima: Uprima (apomorphine) comes in a tablet form that
dissolves under the tongue. Uprima works by stimulating the brain chemical
dopamine, which heightens sexual interest and sensations. A small number of
people passed out after taking Uprima, so its release in the U.S. is on hold;
however, it is currently available in Europe. Clinical trials are also
currently being conducted on a nasal spray form of this drug.

Topiglan: Still under dysfunction erectile natural treatment, a cream applied to the
penis called topiglan uses the same drug (condition dysfunction erectile more treatment) that is used in
injection therapy and suppository therapy. If topiglan proves to be safe
and effective, it is still not entirely clear which patients would benefit from
its application and whether patients on injection and suppository therapy would
no longer have to use these techniques.

Avanafil: This newer phosphodiesterase inhibitor is
currently showing promise in clinical trials for the treatment of erectile
dysfunction. Unlike the current oral medications for the treatment of ED, this
one may be able to be taken twice daily for people who want to have intercourse
more than once a day. Further studies are underway.

Melanocortin activators: These are drugs that appear to act
through the central nervous system (for example, the brain). They have been
shown in animal studies to produce an erection. Initial studies in humans
suggest that the drug (PT-141)can be effective if administered intranasally
(through the nose) in men with mental rather than physical causes of ED and
mild to moderate ED. Larger studies will be necessary to dysfunction help
the safety
and overall erectile dysfunction in young man
of these drugs.

Gene therapy: This novel therapy would deliver genes that
produce products or proteins that may not be functioning properly in the penile
tissue of men with ED. Replacement of these proteins may result in improvement
in erectile function. Experimental animal models have demonstrated improvement
in erectile function with gene therapy. Human studies may also demonstrate
success with this therapy. Gene therapy may take a long time for regulatory
approval and public acceptance.

Reviewed by the doctors at the Glickman Urological
Institute at The Cleveland Clinic (2005).